TrialOpen forum infectious diseases2024

Simulated Target Attainment of Multidose Regimens of Dalbavancin for Prolonged Durations of Therapy.

Cecilia F Volk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.